Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 9Melanoma 5Head and Neck Neoplasms 5Stomach Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Thymus Neoplasms 2Skin Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Multiple Myeloma 2Kidney Neoplasms 2Glioblastoma 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

tremelimumab 1durvalumab 1atezolizumab 1Therapeutics 1Immunotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Unresectable Hepatocellular Carcinoma × Immunotherapy × Clear all
NCT05660213 2025-05-20

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Fudan University

Not yet recruiting
750 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡